Alport Syndrome Clinical Trials Alport Syndrome RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Study of ELX-02 in Patients With Alport Syndrome
Condition:   Alport Syndrome Intervention:   Drug: ELX-02 Sponsor:   Eloxx Pharmaceuticals, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 7, 2022 Category: Research Source Type: clinical trials